SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GT who wrote (10746)11/13/1998 8:43:00 AM
From: Gregg Sterner  Read Replies (5) of 119973
 
CTII looks like a it ready take it place.

LINCOLN, R.I., Nov 9 (Reuters) - CytoTherapeutics, Inc., a
developer of gene and cell-based drugs, said Monday the U.S.
Patent Office has allowed its patent application for the use of
its encapsulated cell technology to treat eye diseases.
The company said encapsulated-cell technology is designed
to treat serious ailments by delivering therapeutic substances
directly to body part where they are needed.
CytoTherapeutics stock was up 9/32 at 2-1/8 in midday
trading on the the Nasdaq Stock Market on a volume of 1.4
million shares -- an estimated 10 times its average trading
volume.
The company said the patent provides it with broad coverage
and a "clear commercial pathway" to develop products to treat a
number of serious eye disorders that are poorly treated or
untreatable.
The company said the allowed patent covers methods for
delivering one or more biologically active molecules to the eye
through encapsulated cell implants placed intraocularly,
circumventing the blood-retina barrier, or periocularly.
The company said its encapsulated cell implant technology
potentially avoids problems such as toxicity and tolerance
associated with other forms of drug delivery because the agent
is surgically placed in the body to deliver a desired
therapeutic substance directly where it is needed.

Copyright 1998, Reuters News Service

Companies or Securities discussed in this article:
Symbol Name
NASDAQ:CTII Cytotherapeutics Inc

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News